Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IOLCP | NSE
4.66
6.40%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
01/04/2026
77.43
75.50
78.78
74.96
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API) such as ibuprofen ibuprofen lysinate ibuprofen sodium and dex- ibuprofen; and other APIs including metformin hydrochloride clopidogrel bisulphate pantoprazole sodium ursodeoxycholic acid losartan potassium gabapentin levetiracetam lamotrigine and fenofibrate. Its products are used for treatments which include anti-inflammatory analgesic and antipyretic anti-diabetic anti- platelet anti-cholesterol anti- convulsant anti-cholelithic as well as proton pump inhibitor. The company also provides specialty industrial chemicals comprising ethyl acetate iso butyl benzene acetyl chloride and mono chloro acetic acid for use in food processing flexible packaging pharmaceuticals textiles ink paint pesticides and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is headquartered in Ludhiana India.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
84.0%1 month
63.0%3 months
48.6%6 months
43.4%20.75
-
1.53
0.02
0.01
10.17
1.16
-
2.10B
4.59B
49.25M
1.19
6.83
-34.60
-10.80
8.62
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
11.78
Range1M
13.20
Range3M
17.66
Rel. volume
0.64
Price X volume
85.64M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 185.66 | 4.93B | 0.89% | 61.65 | 4.77% |
| Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 616.2 | 3.53B | 4.97% | 9.51 | 0.87% |
| Zim Laboratories Limited | ZIMLAB | Drug Manufacturers-Specialty & Generic | 64.38 | 3.14B | 6.84% | 29.93 | 45.58% |
| Medico Remedies Limited | MEDICO | Drug Manufacturers-Specialty & Generic | 38.32 | 3.05B | 16.97% | 45.53 | 15.37% |
| Medicamen Biotech Limited | MEDICAMEQ | Drug Manufacturers-Specialty & Generic | 231.64 | 2.86B | 3.73% | 82.74 | 15.37% |
| Bafna Pharmaceuticals Limited | BAFNAPH | Drug Manufacturers-Specialty & Generic | 111.96 | 2.66B | 2.40% | 674.92 | 30.17% |
| Kilitch Drugs (India) Limited | KILITCH | Drug Manufacturers-Specialty & Generic | 138.35 | 2.24B | 11.17% | 42.44 | 17.95% |
| Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 9.76 | 2.21B | 4.95% | 138.07 | 59.44% |
| Lyka Labs Limited | LYKALABS | Biotechnology | 51.17 | 1.83B | 13.84% | 813.94 | 86.05% |
| Aarey Drugs & Pharmaceuticals Limited | AAREYDRUGS | Drug Manufacturers-Specialty & Generic | 53.28 | 1.54B | 4.99% | 32.75 | 23.61% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 151.06 | 4.88B | 9.69% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 57.49 | 1.59B | 4.99% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 83.8 | 1.22B | 13.34% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 65.89 | 734.59M | 4.50% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 22.89 | 397.37M | 3.95% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 6.92 | 151.62M | 14.38% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 10.17 | 24.85 | Cheaper |
| Ent. to Revenue | 1.16 | 11.40 | Cheaper |
| PE Ratio | 20.75 | 51.36 | Cheaper |
| Price to Book | 1.53 | 6.83 | Cheaper |
| Dividend Yield | 1.19 | 0.52 | Leader |
| Std. Deviation (3M) | 48.59 | 42.17 | Par |
| Debt to Equity | 0.02 | 0.35 | Cheaper |
| Debt to Assets | 0.01 | 0.17 | Cheaper |
| Market Cap | 4.59B | 290.82B | Emerging |